The combined treatment of TSS and MI could specifically target key transcription factors, such as Smad3 and NF-κB. Our results indicated that TSS may be a potential choice for the prevention and treatment of ALI. This evidence concerns the gene NFKB1 and acute respiratory distress syndrome.